PMC:7696151 / 44223-44414
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1251 | 38-41 | Chemical | denotes | HCQ | MESH:D006886 |
| 1259 | 116-125 | Disease | denotes | synovitis | MESH:D013585 |
| 1260 | 130-140 | Disease | denotes | joint pain | MESH:D018771 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T69 | 116-125 | Phenotype | denotes | synovitis | http://purl.obolibrary.org/obo/HP_0100769 |
| T70 | 130-140 | Phenotype | denotes | joint pain | http://purl.obolibrary.org/obo/HP_0002829 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T287 | 0-191 | Sentence | denotes | Within 36 weeks and during the study, HCQ showed statistically significant benefits on physical function, mainly on synovitis and joint pain, without side effects with respect to the control. |